Fertility warning
This medicine may affect fertility.
Leaflet MERCAPTOPURINA ACCORD 50mg tablets
- Product code:
- W71593001
- Quantity:
- 24
- Indicated for:
- leukemia
- Route of administration:
- oral
- Substance:
- mercaptopurine (antimetabolite antineoplastic)
- ATC
- L01BB02 — Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Genetic test recommended
A genetic test may be needed before treatment.
Mercaptopurine is a medication used for the treatment of acute lymphoblastic leukemia and other hematological conditions. It works by inhibiting DNA synthesis in cancer cells, thereby preventing their proliferation.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor liver and hematologic function.
Patients should be aware of potential side effects, such as nausea, decreased blood cell counts, or liver impairment. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, decreased blood cell counts, and liver impairment. In rare cases, severe reactions such as liver failure or severe infections may occur. Patients should be informed of these risks before use.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor liver and hematologic function.
Patients should be aware of potential side effects, such as nausea, decreased blood cell counts, or liver impairment. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, decreased blood cell counts, and liver impairment. In rare cases, severe reactions such as liver failure or severe infections may occur. Patients should be informed of these risks before use.
General data about MERCAPTOPURINA ACCORD 50mg
- Substance:
- mercaptopurine
- Date of latest medicines list:
- 01-03-2026
- Product code:
- W71593001
- Concentration:
- 50mg
- Pharmaceutical form:
- tablets
- Quantity:
- 24
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for mercaptopurine
Concentrations available for mercaptopurine
- 20mg/ml
- 50mg